Lidocaine Hydrochloride Bp Mercury Pharmaceuticals

Lidocaine Hydrochloride, the active ingredient in Lidocaine Hydrochloride Bp Mercury Pharmaceuticals, is an amide-type local anesthetic presented as a sterile solution for intravenous use. It provides local anesthesia for minor surgical procedures and can be employed in the management of ventricular arrhythmias in appropriate clinical settings.

GNH USA supplies Lidocaine Hydrochloride Bp Mercury Pharmaceuticals as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Lidocaine Hydrochloride acts on nerve conduction and cardiac electrical activity, making it useful in several clinical contexts. - Minor surgical procedures: provides reversible loss of sensation to facilitate painless operation. - Ventricular arrhythmias: stabilises cardiac rhythm during acute episodes. - Regional nerve block procedures: enables analgesia for diagnostic or therapeutic interventions.

Adverse reactions may occur following intravenous administration of lidocaine.

Common Side Effects: - Tingling or numbness at the injection site - Mild hypotension - Metallic taste in the mouth - Dizziness or light‑headedness - Nausea or vomiting - Transient visual disturbances

Serious or Rare Side Effects: - Seizures or convulsions - Cardiac arrest or severe arrhythmias - Severe allergic reaction (anaphylaxis) - Respiratory depression - Persistent hypotension requiring intervention - Methemoglobinemia

Lidocaine Hydrochloride requires careful patient assessment and monitoring. - Allergy assessment: avoid use in patients with known hypersensitivity to amide‑type local anesthetics. - Cardiac monitoring: observe for arrhythmias or conduction disturbances during IV administration. - Dose adjustment: consider reduced doses in patients with hepatic impairment. - Concurrent CNS depressants: use caution when combined with other agents that lower seizure threshold. - Pregnancy and lactation: safety not established; weigh benefits against potential risks. - Store below 25°C: keep in original container, protect from light and moisture.

Lidocaine Hydrochloride can interact with several drug classes, influencing efficacy and safety.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine, procainamide): additive cardiotoxicity. - Beta‑adrenergic blockers: may potentiate bradycardia. - CYP3A4 inhibitors (e.g., ketoconazole): increase lidocaine plasma concentrations.

Moderate Interactions (Monitor Closely): - Other local anesthetics: risk of cumulative systemic toxicity. - Diuretics (e.g., furosemide): may enhance hypotensive effect. - General anesthetics (e.g., propofol): monitor for additive CNS depression.